Evaluating the Delivery of Care by Telemedicine for Incarcerated People Living with HIV: a Cohort Study

Overview

Journal BMC Infect Dis

Publisher Biomed Central

Specialty Infectious Diseases

Date 2024 Jul 22

PMID 39039476

Authors

Ruth C Dunn

Cassidy J Stegall

Colten Creel

Christian J Fuchs

Barbara E Menzies

Nathan A Summers

Affiliations

Soon will be listed here.

Abstract

Background: The use of telemedicine has grown significantly since the COVID-19 pandemic and has the potential to improve access to specialized care for otherwise underserved populations. Incarcerated people living with HIV (PLWH) could potentially benefit from expanded access to HIV care through telemedicine.

Methods: All PLWH who were incarcerated within the Tennessee Department of Corrections and received care through the HIV telemedicine clinic at Regional One Hospital between 5/1/2019 through 2/28/2022 were identified from the electronic health records (EHR). Demographics, laboratory data, vaccine history, and treatment outcomes were abstracted from the EHR. Retention in care and viral suppression were defined using Centers for Disease Control and Prevention definitions.

Results: Of the 283 incarcerated PLWH receiving care from this telemedicine clinic, 78% remained retained in care and 94% achieved or maintaining viral suppression at 12 months. Many preventative care measures remained unperformed or undocumented, including vaccinations and testing for concurrent sexually transmitted infections. There were 56 patients (20%) found to have chronic hepatitis C in this population, with 71% either cured or still on treatment in this study period.

Conclusions: Retention in care and viral suppression rates were excellent among incarcerated PLWH receiving telemedicine care for their HIV. HIV related primary health care screenings and vaccinations, however, were less consistently documented and represent areas for improvement.

References

Altice F, Mostashari F, Selwyn P, Checko P, Singh R, Tanguay S . Predictors of HIV infection among newly sentenced male prisoners. J Acquir Immune Defic Syndr Hum Retrovirol. 1998; 18(5):444-53. DOI: 10.1097/00042560-199808150-00005. View

Bavinton B, Pinto A, Phanuphak N, Grinsztejn B, Prestage G, Zablotska-Manos I . Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study. Lancet HIV. 2018; 5(8):e438-e447. DOI: 10.1016/S2352-3018(18)30132-2. View

Hays R, Skootsky S . Patient Experience with In-Person and Telehealth Visits Before and During the COVID-19 Pandemic at a Large Integrated Health System in the United States. J Gen Intern Med. 2022; 37(4):847-852. PMC: 8725638. DOI: 10.1007/s11606-021-07196-4. View

Baim-Lance A, Angulo M, Chiasson M, Lekas H, Schenkel R, Villarreal J . Challenges and opportunities of telehealth digital equity to manage HIV and comorbidities for older persons living with HIV in New York State. BMC Health Serv Res. 2022; 22(1):609. PMC: 9073813. DOI: 10.1186/s12913-022-08010-5. View

Lundgren J, Babiker A, Gordin F, Emery S, Grund B, Sharma S . Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. N Engl J Med. 2015; 373(9):795-807. PMC: 4569751. DOI: 10.1056/NEJMoa1506816. View

Rodger A, Cambiano V, Bruun T, Vernazza P, Collins S, Degen O . Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study. Lancet. 2019; 393(10189):2428-2438. PMC: 6584382. DOI: 10.1016/S0140-6736(19)30418-0. View

Burke G, Osman K, Lew S, Ehrhardt N, Robie A, Amdur R . Improving Specialty Care Access via Telemedicine. Telemed J E Health. 2022; 29(1):109-115. DOI: 10.1089/tmj.2021.0597. View

Wood B, Young J, Abdel-Massih R, McCurdy L, Vento T, Dhanireddy S . Advancing Digital Health Equity: A Policy Paper of the Infectious Diseases Society of America and the HIV Medicine Association. Clin Infect Dis. 2020; 72(6):913-919. PMC: 7665352. DOI: 10.1093/cid/ciaa1525. View

Thompson M, Horberg M, Agwu A, Colasanti J, Jain M, Short W . Primary Care Guidance for Persons With Human Immunodeficiency Virus: 2020 Update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2020; 73(11):e3572-e3605. DOI: 10.1093/cid/ciaa1391. View

10.

Iroh P, Mayo H, Nijhawan A . The HIV Care Cascade Before, During, and After Incarceration: A Systematic Review and Data Synthesis. Am J Public Health. 2015; 105(7):e5-16. PMC: 4463395. DOI: 10.2105/AJPH.2015.302635. View

11.

Danila M, Sun D, Jackson L, Cutter G, Jackson E, Ford E . Satisfaction with modes of telemedicine delivery during COVID-19: A randomized, single-blind, parallel group, noninferiority trial. Am J Med Sci. 2022; 364(5):538-546. PMC: 9446840. DOI: 10.1016/j.amjms.2022.06.021. View

12.

Cohen M, Chen Y, McCauley M, Gamble T, Hosseinipour M, Kumarasamy N . Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011; 365(6):493-505. PMC: 3200068. DOI: 10.1056/NEJMoa1105243. View

13.

Colasanti J, Kelly J, Pennisi E, Hu Y, Root C, Hughes D . Continuous Retention and Viral Suppression Provide Further Insights Into the HIV Care Continuum Compared to the Cross-sectional HIV Care Cascade. Clin Infect Dis. 2015; 62(5):648-654. PMC: 4741359. DOI: 10.1093/cid/civ941. View

14.

El-Nahal W, Chander G, Jones J, Fojo A, Keruly J, Manabe Y . Telemedicine Use Among People With HIV in 2021: The Hybrid-Care Environment. J Acquir Immune Defic Syndr. 2023; 92(3):223-230. PMC: 9969325. DOI: 10.1097/QAI.0000000000003124. View

15.

Badowski M, Nyberg C . Establishing a telemedicine clinic for HIV patients in a correctional facility. Am J Health Syst Pharm. 2012; 69(19):1630, 1632-3. DOI: 10.2146/ajhp120053. View

16.

Danel C, Moh R, Gabillard D, Badje A, Le Carrou J, Ouassa T . A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. N Engl J Med. 2015; 373(9):808-22. DOI: 10.1056/NEJMoa1507198. View

17.

Reif S, Whetten K, Wilson E, McAllaster C, Pence B, LeGrand S . HIV/AIDS in the Southern USA: a disproportionate epidemic. AIDS Care. 2013; 26(3):351-9. DOI: 10.1080/09540121.2013.824535. View

18.

Kitahata M, Gange S, Abraham A, Merriman B, Saag M, Justice A . Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med. 2009; 360(18):1815-26. PMC: 2854555. DOI: 10.1056/NEJMoa0807252. View

19.

Samji H, Cescon A, Hogg R, Modur S, Althoff K, Buchacz K . Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS One. 2013; 8(12):e81355. PMC: 3867319. DOI: 10.1371/journal.pone.0081355. View

20.

Young J, Patel M, Badowski M, Mackesy-Amiti M, Vaughn P, Shicker L . Improved virologic suppression with HIV subspecialty care in a large prison system using telemedicine: an observational study with historical controls. Clin Infect Dis. 2014; 59(1):123-6. PMC: 4305134. DOI: 10.1093/cid/ciu222. View